What does CUSIP H17182108 represent in this 13F holders report?

CUSIP H17182108 is the security identifier for CRSP - CRISPR Therapeutics AG - Common Stock used to aggregate holder disclosures.

How many institutions held CRSP - CRISPR Therapeutics AG - Common Stock in Q2 2016?

No institutional holders were reported for CRSP - CRISPR Therapeutics AG - Common Stock in Q2 2016; review adjacent reporting periods for trend context.

CRISPR Therapeutics AG - Common Stock (CRSP)

CUSIP: H17182108

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class: Equity / Common Stock
Shares outstanding: 95,714,968
Total 13F shares: 0
Share change: -40
Total reported value: $0
Price per share: $61.74
Number of holders: 0
Value change: -$1,000
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP H17182108?
CUSIP H17182108 identifies CRSP - CRISPR Therapeutics AG - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2016
Previous quarter: Q1 2016

Recent filing periods for CUSIP H17182108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

CRISPR Therapeutics AG - Common Stock (CRSP)

Q2 2016 13F Holders as of 30 Jun 2016

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of CRSP - CRISPR Therapeutics AG - Common Stock as of Q2 2016.